{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:09:11Z","timestamp":1787170151710,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Marathon Foundation of Tv3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijrobp.2026.03.005","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:25:17Z","timestamp":1773332717000},"page":"87-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A New Predictive Model for Radiation Necrosis Risk Based on PTV-Enriched Blood Inflammatory Biomarkers in Patients With Brain Metastases Treated With Stereotactic Radiosurgery"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-8321","authenticated-orcid":false,"given":"Paola Anna","family":"Jablonska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Zelaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Robledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Echeveste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Flamarique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Moreno-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Bosch-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Aristu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.03.005_bib0001","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/biology12050655","article-title":"Radiation necrosis following stereotactic radiosurgery or fractionated stereotactic radiotherapy with high biologically effective doses for large brain metastases","volume":"12","author":"Johannwerner","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00795-015-0123-2","article-title":"Delayed brain radiation necrosis: pathological review and new molecular targets for treatment","volume":"48","author":"Furuse","year":"2015","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/030098589403100201","article-title":"Astrocytes: Form, functions, and roles in disease","volume":"31","author":"Montgomery","year":"1994","journal-title":"Vet Pathol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814219","article-title":"Presence of activated (phosphorylated) STAT3 in radiation necrosis following stereotactic radiosurgery for brain metastases","volume":"24","author":"Jablonska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","article-title":"Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases","volume":"125","author":"Kohutek","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0006","first-page":"70","article-title":"The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy","volume":"27","author":"Daisne","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0007","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0008","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0009","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1148\/rg.325125002","article-title":"Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence","volume":"32","author":"Shah","year":"2012","journal-title":"Radiographics"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3171\/2024.6.JNS232187","article-title":"Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery","volume":"142","author":"McCall","year":"2024","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0011","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/neuonc\/noaa239","article-title":"Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: Longitudinal assessment by F-DOPA PET","volume":"23","author":"Cicone","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0012","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/neuonc\/noad188","article-title":"The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases","volume":"26","author":"Mayo","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0013","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2016.08.039","article-title":"Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis","volume":"96","author":"Miller","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3171\/jns.2006.104.1.157","article-title":"Assessment of imaging studies used with radiosurgery: A volumetric algorithm and an estimation of its error. Technical note","volume":"104","author":"Snell","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0016","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","article-title":"Multidose stereotactic radiosurgery (9 Gy \u00d7 3) of the postoperative resection cavity for treatment of large brain metastases","volume":"86","author":"Minniti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s40001-023-01178-4","article-title":"Stereotactic radiotherapy for brain metastases: Predictive factors of radionecrosis","volume":"28","author":"Calderon","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0018","article-title":"Predicting radionecrosis after stereotactic radiation therapy for solitary brain metastases: External validation of a univariable model and development of a multivariable model","volume":"10","author":"van Schaik","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.prro.2019.09.014","article-title":"Dosimetric factors related to radiation necrosis after 5-fraction radiosurgery for patients with resected brain metastases","volume":"10","author":"Tanenbaum","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3171\/2017.9.JNS171735","article-title":"Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases","volume":"130","author":"Jhaveri","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0021","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/neuonc\/noz012","article-title":"Liquid biopsy in central nervous system metastases: A RANO review and proposals for clinical applications","volume":"21","author":"Boire","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285646","article-title":"Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study","volume":"18","author":"Makranz","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0023","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1093\/neuros\/nyaa334","article-title":"A liquid biopsy to assess brain tumor recurrence: Presence of circulating Mo-MDSC and CD14+ VNN2+ myeloid cells as biomarkers that distinguish brain metastasis from radiation necrosis following stereotactic radiosurgery","volume":"88","author":"Soler","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10014-008-0233-9","article-title":"Pathological review of late cerebral radionecrosis","volume":"25","author":"Yoshii","year":"2008","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0026","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.3390\/ijms23158286","article-title":"Microglia as therapeutic target for radiation-induced brain injury","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2005.07.980","article-title":"12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors","volume":"64","author":"Korytko","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.10.035","article-title":"Clinical outcomes and relevance of composite V12 Gy in patients with four or more brain metastases treated with single fraction stereotactic radiosurgery","volume":"37","author":"Parikh","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jocn.2012.09.011","article-title":"Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations","volume":"20","author":"Rahmathulla","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0031","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.3390\/cancers13236086","article-title":"Dose-response effect and dose-toxicity in stereotactic radiotherapy for brain metastases: a review","volume":"13","author":"Loo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10147-009-0915-2","article-title":"Radiotherapy for metastatic brain tumors","volume":"14","author":"Shibamoto","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0034","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cancers16193327","article-title":"Fractionated stereotactic intensity-modulated radiotherapy for large brain metastases: comprehensive analyses of dose-volume predictors of radiation-induced brain necrosis","volume":"16","author":"Murai","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-022-01577-x","article-title":"Liquid biopsies to occult brain metastasis","volume":"21","author":"Rehman","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/diseases10010011","article-title":"Emerging biomarkers for diagnosis, prevention and treatment of brain metastases-from biology to clinical utility","volume":"10","author":"Kalita-de Croft","year":"2022","journal-title":"Diseases"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0037","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41591-024-03286-y","article-title":"Prediction of brain metastasis development with DNA methylation signatures","volume":"31","author":"Zuccato","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0038","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1541-7786.MCR-24-0052","article-title":"NSCLC extracellular vesicles containing miR-374a-5p promote leptomeningeal metastasis by influencing blood\u2012brain barrier permeability","volume":"22","author":"Jin","year":"2024","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0039","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41416-022-01744-3","article-title":"Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer","volume":"126","author":"Wei","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncr.21220","article-title":"S100beta as a predictor of brain metastases: brain versus cerebrovascular damage","volume":"104","author":"Vogelbaum","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0041","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41591-022-01749-8","article-title":"Stratification of radiosensitive brain metastases based on an actionable S100A9\/RAGE resistance mechanism","volume":"28","author":"Monteiro","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50298-7","article-title":"CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery","volume":"9","author":"Soike","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0043","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820938279","article-title":"Biomarkers of brain damage induced by radiotherapy","volume":"18","author":"Sultana","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241241162","article-title":"The role of CXCL11 and its receptors in cancer: prospective but challenging clinical targets","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Control"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0045","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/ijms25126532","article-title":"Chemokines and cytokines in immunotherapy of melanoma and other tumors: from biomarkers to therapeutic targets","volume":"25","author":"Reschke","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0046","article-title":"Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: an observational study","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0047","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/2159-8290.CD-21-1115","article-title":"A therapeutically actionable protumoral axis of cytokines involving IL-8, TNF\u03b1, and IL-1\u03b2","volume":"12","author":"Olivera","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0048","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","article-title":"Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors","volume":"26","author":"Schalper","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0049","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.4049\/jimmunol.142.7.2230","article-title":"Soluble CD8 during T cell activation","volume":"142","author":"Tomkinson","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.41.6.851","article-title":"Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis","volume":"41","author":"Maimone","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2026.03.005_bib0051","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/neuonc\/noae077","article-title":"EDA2R reflects the acute brain response to cranial irradiation in liquid biopsies","volume":"26","author":"Lastra Romero","year":"2024","journal-title":"Neuro-Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:34:32Z","timestamp":1786520072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0360301626004888"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Predictive Model for Radiation Necrosis Risk Based on PTV-Enriched Blood Inflammatory Biomarkers in Patients With Brain Metastases Treated With Stereotactic Radiosurgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}